Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Category | Mid Cap | Mid Cap |
| Plan | Regular | Regular |
| Fund house | Nippon India | Mirae Asset |
| NAV | ₹4,471.1655 | ₹39.3990 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 7.3 years |
| Expense ratio | 1.5% | 2.0% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 69.30 | 42.30 |
Returns
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| 1 month | +5.38% | +5.29% |
| 3 months | −2.22% | −3.13% |
| 6 months | +2.18% | +3.78% |
| YTD | +5.84% | +3.29% |
| 1 year | +4.39% | +3.13% |
| 3 years (CAGR) | +15.54% | +13.87% |
| 5 years (CAGR) | +16.08% | +13.04% |
| 10 years (CAGR) | +18.18% | — |
| Since launch | +15.35% | +20.75% |
Risk
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Volatility | 17.9% | 18.7% |
| Downside volatility | 11.8% | 12.9% |
| Sharpe | 0.50 | 0.39 |
| Sortino | 0.76 | 0.57 |
| Calmar | 0.77 | 0.61 |
| Return / risk | 0.87 | 0.74 |
| Deepest fall | −62.65% | −37.48% |
| Days to recover | 546 | 214 |
| Below its high | −2.78% | −4.40% |
Against benchmark
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Alpha | +1.61% | +0.13% |
| Beta | 0.96 | 1.01 |
| R² | 95.9% | 97.6% |
| Up capture | 99.0% | 101.6% |
| Down capture | 91.6% | 102.0% |
| Tracking error | 3.7% | 2.9% |
| Information ratio | 0.35 | 0.06 |
| Treynor | 0.08 | 0.07 |
Consistency
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Best 1-year | +136.86% | +116.14% |
| Middle 1-year | +12.56% | +16.54% |
| Worst 1-year | −56.31% | −5.35% |
| 1-year periods with a loss | 22.0% | 6.8% |
| Middle 3-year | +17.53% | +21.91% |
| Positive months | 69.4% | 66.7% |
| Best day | +4.57% | +3.90% |
| Worst day | −7.42% | −6.40% |
| Worst 5% day | −1.82% | −1.86% |
| Positive days | 54.9% | 57.0% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| 5-year XIRR | +16.46% | +13.78% |
| 5-year value | ₹9,12,789 | ₹8,53,412 |
| 3-year XIRR | +9.32% | +8.98% |
| 1-year XIRR | +7.21% | +7.32% |
Holdings overlap i
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Nippon India Growth Mid Cap Fund | — | 30% |
| Mirae Asset Midcap Fund | 30% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund |
|---|---|---|
| The Federal Bank Limited | 2.85% | 3.30% |
| BSE Limited | 2.73% | 2.23% |
| Persistent Systems Limited | 2.03% | 3.17% |
| One 97 Communications Limited | 2.37% | 1.89% |
| Bharat Forge Limited | 1.79% | 2.43% |
| Mankind Pharma Limited | 1.99% | 1.65% |
| Gland Pharma Limited | 1.77% | 1.55% |
| Voltas Limited | 1.49% | 2.34% |
| Bharat Heavy Electricals Limited | 1.35% | 1.50% |
| FSN E-Commerce Ventures Limited | 1.20% | 1.52% |
| Prestige Estates Projects Limited | 1.11% | 2.26% |
| Indian Bank | 1.08% | 2.05% |
| Dixon Technologies (India) Limited | 0.94% | 2.54% |
| Ge Vernova T&D India Limited | 1.97% | 0.92% |
| Lupin Limited | 0.90% | 3.43% |
| Swiggy Limited | 0.87% | 1.50% |
| Max Financial Services Limited | 1.20% | 0.79% |
| HDB Financial Services Limited | 0.72% | 2.19% |
| Multi Commodity Exchange of India Limited | 3.20% | 0.68% |
| Schaeffler India Limited | 0.66% | 1.11% |
| Vishal Mega Mart Limited | 0.60% | 1.52% |
| Gujarat Fluorochemicals Limited | 0.53% | 0.74% |
| Dalmia Bharat Limited | 0.47% | 1.88% |
| Container Corporation Of India Limited | 0.44% | 1.39% |
| 3M India Limited | 0.36% | 1.30% |
Sectors and company size
| Nippon India Growth Mid Cap Fund | Mirae Asset Midcap Fund | |
|---|---|---|
| Large companies | 22.4% | 12.7% |
| Mid companies | 66.0% | 68.0% |
| Small companies | 11.5% | 15.6% |
| Top 10 holdings | 25.7% | 32.3% |
| Largest sector | Banks 10% | Pharmaceuticals & Biotechnology 12% |